Literature DB >> 30431

Clinical significance of an increased or decreased serum alkaline phosphatase level.

P L Wolf.   

Abstract

An increase in the level of serum alkaline phosphatase (ALP) may be caused by a wide variety of pathologic lesions that involve multiple organs, since the enzyme is an ubiquitous one. Before one attempts to identify a significant pathologic abnormality, the clinician should consider the possibility of a physiologic or spurious cause for an increased level of ALP. A decreased ALP level also has diagnostic value.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 30431

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  9 in total

Review 1.  Clinical use of serum enzymes in liver disease.

Authors:  J J Reichling; M M Kaplan
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

2.  Persistently increased intestinal fraction of alkaline phosphatase.

Authors:  E Nathan; G Baatrup; H Berg; B Lund-Hansen; S Reinholdt
Journal:  Eur J Pediatr       Date:  1984-06       Impact factor: 3.183

3.  ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.

Authors:  Paul Y Kwo; Stanley M Cohen; Joseph K Lim
Journal:  Am J Gastroenterol       Date:  2016-12-20       Impact factor: 10.864

Review 4.  Misleading biochemical laboratory test results.

Authors:  A A Nanji
Journal:  Can Med Assoc J       Date:  1984-06-01       Impact factor: 8.262

Review 5.  Alkaline phosphatase: a potential biomarker for stroke and implications for treatment.

Authors:  Allison L Brichacek; Candice M Brown
Journal:  Metab Brain Dis       Date:  2018-10-04       Impact factor: 3.584

6.  An investigation of the mouse as a model for vincristine toxicity.

Authors:  S D Harrison
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

7.  Biochemical diagnosis of liver disease.

Authors:  P L Wolf
Journal:  Indian J Clin Biochem       Date:  1999-01

8.  Myocardial oxidative stress, osteogenic phenotype, and energy metabolism are differentially involved in the initiation and early progression of delta-sarcoglycan-null cardiomyopathy.

Authors:  Comlan Missihoun; David Zisa; Arsalan Shabbir; Huey Lin; Techung Lee
Journal:  Mol Cell Biochem       Date:  2008-08-26       Impact factor: 3.396

9.  Oral acute and sub-chronic toxicity assessment of aqueous leaf extract of Simarouba glauca DC (Paradise tree).

Authors:  Sd E Osagie-Eweka; N E J Orhue; E K I Omogbai; F C Amaechina
Journal:  Toxicol Rep       Date:  2021-01-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.